The influence of Methylprednisolone and Erythropoietin to spinal cord injury:microarray data analysis
碩士 === 臺北醫學大學 === 醫學資訊研究所 === 97 === Treatment of spinal cord injury (SCI) has been a frustrating endeavor in neurological medicine because SCI causes a series of devastating damage. The current treatment of SCI is restricted in the high-dose glucocorticoid drug. The anti-inflammatory therapy, Meth...
Main Authors: | Meng-Yu Tsai, 蔡孟瑜 |
---|---|
Other Authors: | 李元綺 |
Format: | Others |
Language: | zh-TW |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/92844672221757340793 |
Similar Items
-
Erythropoietin Plus Methylprednisolone or Methylprednisolone in the Treatment of Acute Spinal Cord Injury: a Preliminary Report
by: Ehsanali Alibai, et al.
Published: (2014-04-01) -
Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone
by: Okan Ozkunt, et al.
Published: (2017-11-01) -
Patients with Spinal Cord Injuries Favor Administration of Methylprednisolone.
by: Christian A Bowers, et al.
Published: (2016-01-01) -
Methylprednisolone– acute spinal cord injury, benefits or risks?
by: Maciej Tęsiorowski, et al.
Published: (2013-06-01) -
Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
by: Christian A Bowers, et al.
Published: (2016-01-01)